Abbott Laboratories - Selling General and Administrative
Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Selling-General-and-Administrative" stands at 9.92 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 03/31/2021.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -17.01 percent compared to the value the year prior.
The 1 year change in percent is -17.01.
The 3 year change in percent is -9.99.
The 5 year change in percent is -5.03.
The 10 year change in percent is 46.83.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2026, is +48.68%.
The Serie's change in percent from it's maximum value, on 03/31/2026, to it's latest available value, on 06/30/2026, is -23.75%.
Selling General and Administrative for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Intuitive Surgical Inc - Selling General and Administrative | 206,245,888,000.00 |
 | EssilorLuxottica S. A. - Selling General and Administrative | 172,241,486,586.05 |
 | Danaher Corporation - Selling General and Administrative | 162,006,663,168.00 |
 | Boston Scientific Corp - Selling General and Administrative | 144,567,730,176.00 |
 | Stryker Corporation - Selling General and Administrative | 139,209,850,880.00 |